Search Results - "Intranasal administration"
-
1
Authors: et al.
Source: Journal of Dispersion Science & Technology. 2026, Vol. 47 Issue 11, p2408-2422. 15p.
Subject Terms: *Resveratrol, *Intranasal administration, *Pharmacokinetics, *Bioavailability, *Microemulsions, *Neurodegeneration, *Experimental design
HTML Full Text PDF Full Text -
2
Authors: et al.
Source: Journal of Chemical Health Risks. 2026, Vol. 16 Issue 4, p4783-4795. 13p.
PDF Full Text -
3
Authors:
Source: Journal of Chemical Health Risks. 2026, Vol. 16 Issue 4, p897-907. 11p.
PDF Full Text -
4
Authors: et al.
Source: Animals (2076-2615). Sep2026, Vol. 16 Issue 18, p2877. 27p.
HTML Full Text PDF Full Text -
5
Authors:
Source: Substance Use & Misuse. 2026, Vol. 61 Issue 11, p1846-1854. 9p.
Subjects: Substance abuse, Health literacy, Drug overdose, Scale analysis (Psychology), Drug adulteration, Patient education, Occupational roles, Research funding, T-test (Statistics), Statistical hypothesis testing, Intranasal administration, United States. Dept. of Veterans Affairs, Descriptive statistics, Harm reduction, Longitudinal method, Narcotics, Quality assurance, Data analysis software, Naloxone, Fentanyl, Patient self-monitoring
Geographic Terms: California
HTML Full Text PDF Full Text -
6
Authors: et al.
Source: Pharmaceutics. Sep2026, Vol. 18 Issue 9, p1168. 35p.
HTML Full Text PDF Full Text -
7
Authors: et al.
Source: Pharmaceutics. Sep2026, Vol. 18 Issue 9, p1128. 19p.
HTML Full Text PDF Full Text -
8
Authors: et al.
Source: Pharmaceutics. Sep2026, Vol. 18 Issue 9, p1073. 31p.
HTML Full Text PDF Full Text -
9
Authors: et al.
Source: Pharmaceuticals (14248247). Sep2026, Vol. 19 Issue 9, p1425. 33p.
HTML Full Text PDF Full Text -
10
Authors: et al.
Source: CNS Neuroscience & Therapeutics. Aug2026, Vol. 32 Issue 8, p1-13. 13p.
HTML Full Text PDF Full Text -
11
Authors:
Source: Iranian Journal of Basic Medical Sciences. Nov2026, Vol. 29 Issue 11, p1617-1630. 14p.
PDF Full Text -
12
Authors: et al.
Source: Turkish Journal of Chemistry. 2026 Special Issue, Vol. 50, p438-447. 10p.
PDF Full Text -
13
Authors:
Source: Saudi Journal of Anaesthesia. Jul-Sep2026, Vol. 20 Issue 3, p638-643. 6p.
HTML Full Text PDF Full Text -
14
Authors: Jafarbeglou, Majid1 (AUTHOR) majid.beglou@gmail.com
Source: Veterinary Medicine & Science. Jul2026, Vol. 12 Issue 4, p1-24. 24p.
HTML Full Text PDF Full Text -
15
Authors: et al.
Source: Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p5029. 17p.
HTML Full Text PDF Full Text -
16
Authors: et al.
Source: Journal of Chemical Health Risks. 2026, Vol. 16 Issue 3, p5552-5561. 10p.
PDF Full Text -
17
Authors: et al.
Source: Pharmaceutics. Jul2026, Vol. 18 Issue 7, p766. 32p.
HTML Full Text PDF Full Text -
18
Authors: et al.
Source: Advances in Human Biology. Jul-Sep2026, Vol. 16 Issue 3, p479-488. 10p.
HTML Full Text PDF Full Text -
19
Development and Fabrication of Zavegepant Loaded Mucoadhesive Microemulsion for Intranasal Delivery.
Authors: et al.
Source: Kurdistan Journal of Applied Research (KJAR). Jun2026, Vol. 11 Issue 1, p1-21. 21p.
PDF Full Text -
20
Authors: et al.
Source: Journal of Xenobiotics. Jun2026, Vol. 16 Issue 3, p100. 20p.
HTML Full Text PDF Full Text
A nasally delivered ferroptosis nano-inhibitor for spinal cord injury repair
Age-related emergence of behavioral deficits and amyloid pathology in the J20 mouse model of Alzheimer's disease
Intranasal delivery of engineered macrophage-membrane-coated nanoparticles with enhanced Dectin-1 expression for targeted therapy of cryptococcal meningitis
Polyphenol-engineered selenium nanocatalysts enable neuroprotective glioblastoma chemoimmunotherapy via nose-to-brain delivery
Development, Optimization, and Evaluation of Chitosan Nanoparticles for Co-Delivery of Rivastigmine and Harmaline via Intranasal Route for Brain Targeting
Validation of a Sustainable Stability Indicating Simultaneous RP-HPLC Method for a Novel Cubosomal Formulation Containing Duloxetine Hydrochloride and Olanzapine
Does Route of Administration Matter for Gepant Safety? A Comparative Disproportionality Analysis of Intranasal Zavegepant Using the FDA Adverse Event Reporting System
Topical Delivery of Itraconazole by Clove Oil Based Nanoemulgel for Inhibition of 1ZAP Protein in Candida albicans : Formulation, Optimization, In Silico Study, and Antimicrobial Evaluation
Comparative Formulation and Evaluation of Ginger Nano-emulgel and Glucosamine Sulphate Gel for Adjunctive Periodontal Therapy